Skip to main content
. 2021 Mar;19(3):402–432. doi: 10.2174/1570159X18666200420085712

Table 1.

Patterns of cannabinoid use from observational studies.

Author, Year Study Type Legalization (Location) Number of Participants (SCI/Total) Inclusion
Criteria
Exclusion Criteria Male/Female/
Transgender
Mean Age Tetraplegia/ Paraplegia/ Unknown Mean Time Since Injury Prevalence
Dunn & Davis, 1974 [63] Cross-sectional Illegal (Florida, USA) 10/10 SCI patients using cannabis - 10/0/0 NR NR NR N/A- cannabis use was inclusion criteria
Malec et al., 1982 [64] Cross-sectional Illegal
(Wisconsin, USA)
43/43 SCI patients - 38/5/0 NR NR NR Within last yr: 56%
Heinemann
et al., 1991 [65]
Case-series Illegal
(Illinois, USA)
86/86 13-66 age, 2+ yr since tSCI, English language, no cognitive impairment - 59/27/0 39.5
(13-65)
47/39 13.1 ± 10.2 6 mo pre-SCI: 31%; Post-SCI: 42%
Rothstein
et al., 1992 [66]
Cross-sectional MC legal (New York, USA) 153/153 Male veterans with SCI - 153/0/0 53 ± 1 (20-76) NR NR Current (urinary cannabinoid test): 10%
Young et al., 1995 [43] Cross-sectional Illegal (Texas, USA) 123/123 17+ age, 9+ mo since tSCI, residual motor disability with assistive walking device if ambulatory - 82/41/0 36 ± 10.9 (19-76) Complete tetra: 53, complete para: 53, incomplete: 17 9.7 ± 6.6 Current (regular basis at time of study): 16%
Kolakowsky-Hayner et al., 2002 [67] Cross-sectional Illegal (Virginia, USA) 30/60 SCI and brain injury patients treated in trauma centre - 56/4/0 35.0 ± 10.85 NR 1.4 Past 6-12 mo: 50% among illicit drug users (n=6 SCI, n=1 TBI)
Warms et al., 2002 [68] Cross-sectional MC legal starting Nov 1998, study V1 Feb 1997 – Jul 1998, V2 Aug 1998 – June 2000 (Washington, USA) 471/471 18+ age, 6+ mo since SCI - 334/137/0 42.5 ± 13.2
(18-84)
240/221, unknown: 9 NR Ever: 3%
Grotenhermen & Schnellea, 2003 [51] Cross-sectional Dronabinol prescription
and ∆9-THC special permit (Germany)
and permit (Switzerland)
4/165 Members of Association for Cannabis as Medicine No severe disease 101/64/0 Median age: 40.3 ± 12.4 (16-87) NR NR Ever: 87%
Gortera, 2005 [52] Cross-sectional MC legal (Netherlands) ?/107 Members of Multiple Sclerosis society - 48/59/0 Median age: 58.0 NR NR N/A- MC was inclusion criteria
Cardenas & Jensen, 2006 [53] Cross-sectional MC legal (Washington, USA) 117/117 18+ age, tSCI, chronic pain Incomplete questionnaires 85/32/0 48.8 ± 11.7
(21-79)
56/61 17.3 ± 10.9 Ever: 32%; Current: 20%
Mahoney
et al., 2007 [69]
Interview Illegal (Texas, USA) 24/24 1+ yr since SCI, spasticity, English language - 17/7/0 45.1
(21-68)
13/11 16 NR
Aggarwal
et ala., 2009 [46]
Retrospective chart review MC legal (Washington, USA) 5/139 18+ age, pain clinic patients, access to MC with valid doctor documentation Cannabinoid receptor 1 blocker drug rimonabant 88/51/0 Median age: 48 (18-84) NR NR N/A- MC was inclusion criteria
Author, Year Study Type Legalization (Location) Number of Participants (SCI/Total) Inclusion
Criteria
Exclusion
Criteria
Male/
Female/
Transgender
Mean Age Tetraplegia/ Paraplegia/
Unknown
Mean Time Since Injury Prevalence
Heutink et al., 2011 [70] Cross-sectional MC legal starting 2003, study 1990-2005 (the Netherlands) 279/279 18+ age, SCI rehab patients, living in community - 173/106/0 51.3 ± 14.0 (25-81) 103/165, unknown: 11 11.6 ± 10.7 Past, discontinued: 6%; Current (at study): 3%
Hwang et al., 2012 [48] Cross-sectional Illegal (Florida, USA) 215/215 SCI before age 19, current age 21-25, former hospital patient - 127/88/0 23.4 ± 0.9 112/101, unknown: 2 10.2 ± 4.9 Current (at least mo): 11%
Fekete et al., 2015 [42] Cross-sectional MC permit (Switzerland) 511/511 16+ age, tSCI or non-tSCI; New SCI with palliative care, neurodegenerative diseases or Guillain-Barre syndrome; congenital conditions leading to SCI 373/138/0 52.9 ± 14.8 158/353 17.6 ± 13.0 Current (last 30 d): 7%
Shroff, 2015 [54] Interview MC legal (Canada) 53/53 19-65 age, 1+ years since SCI, BC resident, member of paraplegic association - 42/11/0 NR NR NR NR
Drossel et al., 2016 [45] Cross-sectional MC legal (Michigan & California, USA) 244/244 18+ age, 5+ years since tSCI, English language, neurogenic bowel and/or bladder, no cognitive limitations - 181/63/0 49.7 134/110 18.6 Ever: 23%
Andresen et al., 2017 [44] Cross-sectional MC legal starting 2011, study 1990-2012 (Denmark) 537/537 Inclusion: 18+ age, acquired tSCI, rehab clinic patients Incomplete questionnaires 413/124/0 54.6 ± 14.6 (18-88) 247/263, unknown: 27 18.2 ± 12.8 Ever: 36%; Current (last 2 yrs): 9%
Clark et al., 2017 [47] Cross-sectional MC illegal (Georgia & South Carolina, USA) 1619/1619 18+ age, 1+ year since tSCI, some residual impairment No painful condition, no prescription pain med 1166/453/0 49.3 ± 14.2 453/1166 11.5 ± 9.2 Current (mo): 16%
Patel et al., 2017 [71] Retrospective chart review MC legal (Canada) 19/19 Patients of mobility clinic with documented SCI - 14/5/0 46.7 (18-89) NR NR Current: 16%
Bruce
et al.a, 2018 [50]
Interview MC legal (Illinois, USA) 6/30 18+ age, smoked MC in past 3 mo, qualifying health condition for MC - 19/11/0 44.6 ± 15.9 NR NR N/A- MC was inclusion criteria
Hawley
et al., 2018 [49]
Cross-sectional MC and recreational legal (Colorado, USA) 51/116 SCI rehab patient - 95/21/0 47.1 ± 13.8 (22-74) Tetra ABC: 38, para ABC: 31, tetra/para D: 41, unknown: 5 13.0 Before injury: 67%; After injury: 53%
Bourke
et al., 2019 [72]
Interview Illegal (New Zealand) 8/8 18+ age, SCI patients using cannabis for pain, residing in New Zealand, English speaking, Comorbid conditions inhibiting communication and participation in interview 6/2/0 Age 20-39: n = 1, 40-59: n= 5, 60+: n=2 Tetra: 6
Para: 2
NR N/A- MC was inclusion criteria
Author, Year Study Type Legalization (Location) Number of Participants (SCI/Total) Inclusion Criteria Exclusion Criteria Male/
Female/
Transgender
Mean Age Tetraplegia/ Paraplegia/
Unknown
Mean Time Since Injury Prevalence
Eldridge
et al., 2019 [73]
Retrospective chart review Illegal
(Indiana, USA)
20/20 18+ age, SCI patients received medical care at Eskenazi Medical Center - 17/3/0 45.05 ± 13.84 NR NR Before injury: 25%
Graupensperger et al., 2019 [74] Retrospective chart review MC legal starting 2016 and implemented Feb 2018, study Jan 1997-April 2018 (Pennsylvania, USA) 6192/1466985 16+ age, patients at Penn State Hershey Medical Center - 3368/2824/0 NR NR NR Cannabis use disorder with SCI: 1% vs. non-SCI 0.2%
Stillman et al., 2019 [75] Cross-sectional 39 states in USA, not disclosed; mixed legality 353/353 SCI patients included in mailing lists maintained by Thomas Jefferson
University, University of Washington at Seattle,
and Uni- versity of
Alabama at Birmingham
- 183/107/3 52.74 (19-82) NR 17.49 Current: 39%
Past: 15%

Abbreviations: d: days; freq: frequency; MC: medical cannabis; mo: monthly; N/A: not applicable; NR: not reported; qd: daily; SCI: spinal cord injury; TBI: traumatic brain injury; THC: tetrahydrocannabinol; tSCI: traumatic spinal cord injury, wk: weekly; yr: yearly. adata listed not limited to people with SCI.